Literature DB >> 20098342

Phenotypic and genotypic variability in four males with MECP2 gene sequence aberrations including a novel deletion.

Stavroula Psoni1, Christalena Sofocleous, Joanne Traeger-Synodinos, Sophia Kitsiou-Tzeli, Emmanuel Kanavakis, Helen Fryssira-Kanioura.   

Abstract

The MECP2 gene mutations cause Rett syndrome (RTT) (OMIM: 312750), an X-linked dominant disorder primarily affecting girls. Until RTT was considered lethal in males, although now approximately 60 cases have been reported. Males with MECP2 mutations present with a broad spectrum of phenotypes ranging from neonatal encephalopathy to nonsyndromic mental retardation (MR). Four boys (aged, 3-11 y) were evaluated for MR. Patient 1 had autistic features. Patients 2 and 3 were brothers both presenting with psychomotor delay. Patient 4 showed dysmorphic features and behavioral problems reminiscent of FXS. All patients had a normal 46, XY karyotype and three were tested for FXS with negative results. MECP2 gene analysis of exons 3 and 4 was performed using methods based on the PCR, including Enzymatic Cleavage Mismatched Analysis (ECMA) and direct sequencing. Patient 1 presented somatic mosaicism for the classic RTT p.R106W mutation and patient 4 carried the p.T203M polymorphism. Analysis of the mothers in both cases revealed normal DNA sequences. Patients 2 and 3 had a novel deletion (c.1140del86) inherited from their unaffected mother. MECP2 gene mutations may be considered a rare cause of MR in males although great phenotypic variation hinders genotype-phenotype correlation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20098342     DOI: 10.1203/PDR.0b013e3181d4ecf7

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

Review 1.  Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes.

Authors:  Mahdi Rizk; Zahraa Saker; Hisham F Bahmad; Sanaa Nabha; Hayat Harati; Youssef Fares
Journal:  Mol Biol Rep       Date:  2021-03-01       Impact factor: 2.316

Review 2.  Two new Rett syndrome families and review of the literature: expanding the knowledge of MECP2 frameshift mutations.

Authors:  Kirstine Ravn; Gitte Roende; Morten Duno; Kathrine Fuglsang; Kristin L Eiklid; Zeynep Tümer; Jytte B Nielsen; Ola H Skjeldal
Journal:  Orphanet J Rare Dis       Date:  2011-08-30       Impact factor: 4.123

3.  Genetic Analysis of MECP2 Gene in Iranian Patients with Rett Syndrome.

Authors:  Jafar Nasiri; Mansoor Salehi; Majid Hosseinzadeh; Mahdi Zamani; Shirin Fattahpour; Omid Aryani; Esmat Fazel Najafabadi; Maryam Jabarzadeh; Sara Asadi; Tahereh Gholamrezapour; Maryam Sedghi; Fatemeh Ghorbani
Journal:  Iran J Child Neurol       Date:  2019

4.  Genomic mosaicism in the pathogenesis and inheritance of a Rett syndrome cohort.

Authors:  Qingping Zhang; Xiaoxu Yang; Jiaping Wang; Jiarui Li; Qixi Wu; Yongxin Wen; Ying Zhao; Xiaoying Zhang; He Yao; Xiru Wu; Shujie Yu; Liping Wei; Xinhua Bao
Journal:  Genet Med       Date:  2018-11-08       Impact factor: 8.822

5.  A rare case of a male child with post-zygotic de novo mosaic variant c.538C > T in MECP2 gene: a case report of Rett syndrome.

Authors:  Frenny Sheth; Harsh Sheth; Jhanvi Shah; Harsh Patel; Deepika Jain
Journal:  BMC Neurol       Date:  2021-12-02       Impact factor: 2.474

6.  High-fat diet accelerates extreme obesity with hyperphagia in female heterozygous Mecp2-null mice.

Authors:  Shota Fukuhara; Hisakazu Nakajima; Satoru Sugimoto; Kazuki Kodo; Keiichi Shigehara; Hidechika Morimoto; Yusuke Tsuma; Masaharu Moroto; Jun Mori; Kitaro Kosaka; Masafumi Morimoto; Hajime Hosoi
Journal:  PLoS One       Date:  2019-01-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.